Cited by 2,251Clinical practice guidelines implementationHealth Promotion and Cardiovascular PreventionCoronary Interventions and Diagnostics

The DOI matches its Crossref record.

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

De Backer, G·2003·European Heart Journal

DOI 10.1016/s0195-668x(03)00347-6

Open this paper in CoChat — free account

Abstract

Guidelines aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decision-making. A great number of guidelines have been issued in recent years by different organizations-European Society of Cardiology (ESC), American Heart Association (AHA), American College of Cardiology (ACC), and other related societies. By means of links to web sites of National Societies several hundred guidelines are available. This profusion can put at stake the authority and validity of guidelines, which can only be guaranteed if they have been developed by an unquestionable decision-making process. This is one of the reasons why the ESC and others have issued recommendations for formulating and issuing guidelines. In spite of the fact that standards for issuing good quality guidelines are well defined, recent surveys of guidelines published in peer-reviewed journals between 1985 and 1998 have shown that methodological standards were not complied with in the vast majority of cases. It is therefore of great importance that guidelines and recommendations are presented in formats that are easily interpreted. Subsequently, their implementation programmes must also be well conducted. Attempts have been made to determine whether guidelines improve the quality of clinical practice and the utilization of health resources. In addition, the legal implications of medical guidelines have been discussed and examined, resulting in position documents, which have been published by a specific Task Force.

Integrity signals

Registry

Crossref · 10.1016/s0195-668x(03)00347-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 999

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys
Groups*, T. E. I. A. I., Pyörälà, K., Lehto, S., Bacquer, D. D., SUTTER, J. D., Sans, S., Keil, U., Wood, D., & Backer, G. D. (2004) · Diabetologia · doi:10.1007/s00125-004-1438-z · Cited by 118
Self-citation
Carotenoids and health in older people
Woodside, J. V., McGrath, A. J., Lyner, N., & McKinley, M. C. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.10.012 · Cited by 116
A COmparative study with rosuvastatin in subjects with METabolic Syndrome: results of the COMETS study†
Stalenhoef, A. F. H., Ballantyne, C. M., Sarti, C., Murín, J., Tonstad, S., Rose, H., & Wilpshaar, W. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi482 · Cited by 116
Parental Occurrence of Premature Cardiovascular Disease Predicts Increased Coronary Artery and Abdominal Aortic Calcification in the Framingham Offspring and Third Generation Cohorts
Parikh, N. I., Hwang, S., Larson, M. G., Cupples, L. A., Fox, C. S., Manders, E. S., Murabito, J. M., Massaro, J. M., Hoffmann, U., & O’Donnell, C. J. (2007) · Circulation · doi:10.1161/circulationaha.107.705202 · Cited by 118
Leisure time but not occupational physical activity significantly affects cardiovascular risk factors in an adult population
Sofi, F., Capalbo, A., Marcucci, R., Gori, A. M., Fedi, S., Macchi, C., Casini, A., Surrenti, C., Abbate, R., & Gensini, G. F. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01884.x · Cited by 110
Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study
Lanas, Á., Tornero, J., & Zamorano, J. L. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123166 · Cited by 115
Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial
Voogdt-Pruis, H. R., Beusmans, G. H., Gorgels, A. P., Kester, A. D., & Van Ree, J. W. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x482095 · Cited by 114
Risk Associated With the Metabolic Syndrome Versus the Sum of Its Individual Components
Sundström, J., Vallhagen, E., Risérus, U., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0664 · Cited by 114
Effects of Niacin on Glucose Control in Patients With Dyslipidemia
Goldberg, R. B., & Jacobson, T. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.470 · Cited by 112
Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study
Hermes, W., Franx, A., van Pampus, M. G., Bloemenkamp, K. W. M., Bots, M. L., van der Post, J., PORATH, M. M., Ponjee, G. A. E., Tamsma, J. T., Mol, B. W., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.02.016 · Cited by 112
The role of nutraceuticals in the prevention of cardiovascular disease
Sosnowska, B., Penson, P. E., & Banach, M. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.03.20 · Cited by 117
Machine learning in cardiac CT: Basic concepts and contemporary data
Singh, G., Alaref, S. J., van Assen, M., Kim, T. S., van Rosendael, A., Kolli, K. K., Dwivedi, A., Maliakal, G., Pandey, M. K., Wang, J., et al. (2018) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2018.04.010 · Cited by 113
Monitoring treatment fidelity in a randomized controlled trial of a complex intervention
Spillane, V., Byrne, M. C., Byrne, M., Leathem, C. S., O’Malley, M., & Cupples, M. E. (2007) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2007.04386.x · Cited by 111
Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey
Heuschmann, P. U., Kircher, J., Nowe, T., Dittrich, R., Reiner, Ž., Cífková, R., Malojčić, B., Mayer, O., Bruthans, J., Włoch-Kopeć, D., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314546825 · Cited by 112
Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-Blind, randomized, placebo-controlled study
Lai, J., Wu, B., Xuan, T., Liu, Z., & Chen, J.-Z. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-1 · Cited by 112
Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II
Ballantyne, C. M., Bertolami, M. C., García, H. R. H., Nul, D. R., Stein, E. A., Théroux, P., Weiss, R., Cain, V. A., & Raichlen, J. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.12.013 · Cited by 112
Vitamins B in grain and cereal–grain food, soy-products and seeds
Lebiedzińska, A., & Szefer, P. (2005) · Food Chemistry · doi:10.1016/j.foodchem.2004.12.024 · Cited by 113
Total Cholesterol Content of Erythrocyte Membranes Is Increased in Patients With Acute Coronary Syndrome
Tziakas, D. N., Kaski, J. C., Chalikias, G. K., Romero, C., Fredericks, S., Tentes, I. K., Kortsaris, A. X., Hatseras, D., & Holt, D. W. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.069 · Cited by 109
Reversed-phase high-performance liquid chromatography method with coulometric electrochemical and ultraviolet detection for the quantification of vitamins B1 (thiamine), B6 (pyridoxamine, pyridoxal and pyridoxine) and B12 in animal and plant foods
Lebiedzińska, A., Marszałł, M. L., Kuta, J., & Szefer, P. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.09.072 · Cited by 111
β-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials
Sipahi, İ., Tuzcu, E. M., Wolski, K. E., Nicholls, S. J., Schoenhagen, P., Hu, B., Balog, C., Shishehbor, M. H., Magyar, W. A., Crowe, T. D., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00003 · Cited by 111
Causal attributions, lifestyle change, and coronary heart disease: Illness beliefs of patients of South Asian and European origin living in the United Kingdom
Darr, A., Astin, F., & Atkin, K. M. (2008) · Heart & Lung · doi:10.1016/j.hrtlng.2007.03.004 · Cited by 106
Multiple risk factor interventions for primary prevention of coronary heart disease
Ebrahim, S. B. J., Beswick, A. D., Burke, M., & Smith, G. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub2 · Cited by 117
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Rosselló, X., Raposeiras‐Roubín, S., Oliva, B., Sánchez‐Cabo, F., García-Ruiz, J. M., Caimari, F., Mendiguren, J. M., Lara‐Pezzi, E., Bueno, H., Fernández‐Friera, L., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.335 · Cited by 110
Marine n-3 polyunsaturated fatty acids and coronary heart disease
Schmidt, E. B., Arnesen, H., Caterina, R. D., Rasmussen, L. H., & Kristensen, S. D. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.09.006 · Cited by 105
The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease
Feringa, H. H. H., Karagiannis, S. E., van Waning, V. H., Boersma, E. H., Schouten, O., Bax, J. J., & Poldermans, D. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.01.024 · Cited by 106
Incidence and aetiology of sudden cardiac death in young athletes: an international perspective
Börjesson, M., & Pelliccia, A. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.054718 · Cited by 109
The risk of atherosclerosis in patients with chronic kidney disease
Olechnowicz-Tietz, S., Gluba, A., Paradowska, A., Banach, M., & Rysz, J. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0407-1 · Cited by 105
Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care
Koelewijn-van Loon, M. S., van der Weijden, T., Ronda, G., van Steenkiste, B., Winkens, B., Elwyn, G., & Grol, R. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2009.11.007 · Cited by 105
Impact of time since last caloric intake on blood glucose levels
Moebus, S., Göres, L., Lösch, C., & Jöckel, K. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9608-z · Cited by 107
Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program
Wïttchen, H., Glaesmer, H., März, W., Stalla, G. K., Lehnert, H., Zeiher, A. M., Silber, S., Koch, U., Böhler, S., Pittrow, D., et al. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x38187 · Cited by 104
Effective Prevention of Oxidative Deterioration of Fish Oil: Focus on Flavor Deterioration
Miyashita, K., Uemura, M., & Hosokawa, M. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012320 · Cited by 104
A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels
von Schacky, C. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.251 · Cited by 103
“…Heart Association or the European Society for Cardiology recommend EPA and DHA for prevention of sudden cardiac death, for the treatment after a myocardial infarction and for cardiovascular prevention (Kris-Etherton et al 2002; De Backer et al 2003; Priori et al 2003; van der Werf et al 2003).”
Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study
Getz, L., Sigurdsson, J. A., Hetlevik, I., Kirkengen, A. L., Romundstad, S., & Holmen, J. (2005) · BMJ · doi:10.1136/bmj.38555.648623.8f · Cited by 102
Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005
Marín, R., de la Sierra, Á., Armario, P., Campo, C., Banegas, J. R., & Gorostidi, M. (2005) · Medicina Clínica · doi:10.1157/13076402 · Cited by 106
Primary prevention of stroke: blood pressure, lipids, and heart failure
Endres, M., Heuschmann, P. U., Laufs, U., & Hakim, A. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq472 · Cited by 107
Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
Weng, S. F., Kai, J., Neil, H. A. W., Humphries, S. E., & Qureshi, N. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.034 · Cited by 104
Evaluación y tratamiento de la hipertensión arterial en España. Documento de consenso
de la Sierra, A., Gorostidi, M., Marín, R., Redón, J., Banegas, J. R., Armario, P., Puig, J. G., Zarco, J., Llisterri, J. L., Sanchís, C., et al. (2008) · Medicina Clínica · doi:10.1157/13124015 · Cited by 98
Prevalencia y características de la dislipemia en pacientes en prevención primaria y secundaria tratados con estatinas en España. Estudio DYSIS-España
González‐Juanatey, J. R., Millán, J., Alegría, E., Guijarro, C., Lozano, J. V., & Vitale, G. C. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.030 · Cited by 99
Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores
Mora, S., Redberg, R. F., Sharrett, A. R., & Blumenthal, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.542993 · Cited by 98
Triglycerides and atherogenic dyslipidaemia: Extending treatment beyond statins in the high-risk cardiovascular patient
Watts, G. F., & Karpe, F. (2011) · Heart · doi:10.1136/hrt.2010.204990 · Cited by 97
Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?
Paraskevas, K. I., Liapis, C. D., Hamilton, G., & Mikhailidis, D. P. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.03.009 · Cited by 97
Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study
Sani, M. U., Wahab, K., Yusuf, B. O., Gbadamosi, M., Johnson, O. V., & Gbadamosi, A. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-11 · Cited by 100
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
Manuel, D. G., Kwong, K., Tanuseputro, P., Lim, J., Mustard, C., Anderson, G. M., Ardal, S., Alter, D. A., & Laupacis, A. (2006) · BMJ · doi:10.1136/bmj.38849.487546.de · Cited by 97
The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice
Sattar, N. A., Ginsberg, H. N., Ray, K. K., Chapman, M. J., Arca, M., Averna, M. R., Betteridge, D. J., Bhatnagar, D., Bilianou, E., Carmena, R., et al. (2014) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2014.04.001 · Cited by 99
Exercise Therapy in Hypertensive Cardiovascular Disease
Fagard, R. H. (2011) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2011.03.006 · Cited by 98
Sexual Function and Obstructive Sleep Apnea–Hypopnea: A Randomized Clinical Trial Evaluating the Effects of Oral-Appliance and Continuous Positive Airway Pressure Therapy
Hoekema, A., Stel, A.-L., Stegenga, B., van der Hoeven, J. H., Wijkstra, P. J., van Driel, M. F., & de Bont, L. G. M. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00341.x · Cited by 97
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction
Eussen, S. R. B. M., Geleijnse, J. M., Giltay, E. J., Rompelberg, C. J. M., Klungel, O. H., & Kromhout, D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr499 · Cited by 97
Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain
Sabio, J. M., Zamora‐Pasadas, M., Jiménez‐Jáimez, J., Albadalejo, F., Vargas‐Hitos, J. A., del Águila, M. M. R., Hidalgo-Tenorio, C., González-Gay, M. Á., & Alonso, J. (2008) · Lupus · doi:10.1177/0961203308093554 · Cited by 97
Comparación de la función de Framingham original y la calibrada del REGICOR en la predicción del riesgo coronario poblacional
Ramos, R., Solanas, P., Cordón, F., Rohlfs, I., Elosúa, R., Sala, J., Masiá, R., Faixedas, M. T., & Marrugat, J. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)74007-x · Cited by 99
Obesity, dyslipidemia and brain age in first-episode psychosis
Kolenič, M., Franke, K., Hlinka, J., Matějka, M., Capkova, J., Pausová, Z., Uher, R., Alda, M., Španiel, F., & Hájek, T. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.02.012 · Cited by 98
Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?
Abreu, A., Pesah, E., Supervía, M., Turk-Adawi, K. I., Bjarnason‐Wehrens, B., López-Jiménez, F. A., Ambrosetti, M., Andersen, K. K., Giga, V. L., Vulić, D., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319827453 · Cited by 96
Prediction of Coronary Artery Disease Severity Using CHADS2 and CHA2DS2-VASc Scores and a Newly Defined CHA2DS2-VASc-HS Score
Çetın, M., Çakıcı, M., Zencır, C., Taşolar, H., Baysal, E., Ballı, M., & Aktürk, E. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.056 · Cited by 96
The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering?
Leiter, L. A. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.015 · Cited by 96
Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm
Wassink, A. M. J., van der Graaf, Y., Olijhoek, J. K., Visseren, F. L. J., & for the SMART Study Group (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm582 · Cited by 94
Environmental and occupational exposure to lead as a potential risk factor for cardiovascular disease
Poręba, R., Gać, P., Poręba, M., & Andrzejak, R. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.12.002 · Cited by 97
Global inequality of life expectancy due to AIDS
Dorling, D., Shaw, M., & Smith, G. D. (2006) · BMJ · doi:10.1136/bmj.332.7542.662 · Cited by 94
Statin-induced myositis: a commonly encountered or rare side effect?
Mukhtar, R., & Reckless, J. P. D. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.mol.0000188414.90528.71 · Cited by 93
Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study
Mancia, G., Ambrosioni, E., Rosei, E. A., Leonetti, G., Trimarco, B., & Volpe, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000175932.78774.32 · Cited by 92
Glycemic and Risk Factor Control in Type 1 Diabetes
Eeg‐Olofsson, K., Cederholm, J., Nilsson, P. M., Guðbjörnsdóttir, S., & Eliasson, B. (2007) · Diabetes Care · doi:10.2337/dc06-1406 · Cited by 94
Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study
Nakagami, T., Qiao, Q., Tuomilehto, J. O., Balkau, B., Tajima, N., Hu, G., & Borch‐Johnsen, K. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000183916.28354.69 · Cited by 92
Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy
Bovet, P., Shamlaye, C. F., Gabriel, A., Riesen, W., & Paccaud, F. M. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-9 · Cited by 94
Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone
Piorkowski, M., Fischer, S., Stellbaum, C., Jaster, M., Martus, P., Morguet, A. J., Schultheiss, H., & Rauch, U. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.064 · Cited by 93
A systematic review of fish-oil supplements for the prevention and treatment of hypertension
Campbell, F., Dickinson, H. O., Critchley, J. A., Ford, G. A., & Bradburn, M. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487312437056 · Cited by 93
Lifestyle Index and Work Ability
Kaleta, D., Makowiec-Dąbrowska, T., & Jegier, A. (2006) · International Journal of Occupational Medicine and Environmental Health · doi:10.2478/v10001-006-0021-x · Cited by 93
Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes
Eliasson, B., Cederholm, J., Eeg‐Olofsson, K., Svensson, A.-M., Zethelius, B., Guðbjörnsdóttir, S., & Register, O. B. O. T. N. D. (2011) · Diabetes Care · doi:10.2337/dc11-0209 · Cited by 93
Outcomes of cardiac rehabilitation with versus without a follow-up intervention rendered by telephone (Luebeck follow-up trial): overall and gender-specific effects
Mittag, O., China, C., Hoberg, E., Juers, E., Kolenda, K., Richardt, G., Maurischat, C., & Raspe, H. H. (2006) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0b013e328010ba9a · Cited by 92
Obesity and metabolic changes are common in young childhood brain tumor survivors
Pietilä, S., Mäkipernaa, A., Sievänen, H. T., Koivisto, A., Wigren, T., & Lenko, H. L. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21936 · Cited by 93
Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management
Kajinami, K., Takekoshi, N., Brousseau, M. E., & Schaefer, E. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.09.004 · Cited by 92
Culturally Adapted Hypertension Education (CAHE) to Improve Blood Pressure Control and Treatment Adherence in Patients of African Origin with Uncontrolled Hypertension: Cluster-Randomized Trial
Beune, E., van Charante, E. P. M., Beem, L., Mohrs, J., Agyemang, C. O., Ogedegbe, G. G., & Haafkens, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090103 · Cited by 97
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
Clearfield, M. B., Amerena, J. V., Bassand, J., García, H. R. H., Miller, S. S., Sosef, F., Palmer, M. K., & Bryzinski, B. S. (2006) · Trials · doi:10.1186/1745-6215-7-35 · Cited by 91
Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention
Antoni, M. L., Boden, H., Delgado, V., Boersma, E. H., FOX, K. L., Schalij, M. J., & Bax, J. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr293 · Cited by 90
Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis
Barth, J., Bengel, J., & Critchley, J. (2006) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm3201_2 · Cited by 92
A critical realist approach to understanding and evaluating heart health programmes
Clark, A. M., MACINTYRE, P. D., & Cruickshank, J. (2007) · Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine · doi:10.1177/1363459307080876 · Cited by 90
Prevalence of vascular disease in metabolic syndrome using three proposed definitions
Athyros, V. G., Ganotakis, E. S., Elisaf, M., Liberopoulos, E. N., Goudevenos, I. A., & Karagiannis, A. I. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.078 · Cited by 90
Validation of a point of care lipid analyser using a hospital based reference laboratory
Carey, M., Markham, C. E., Gaffney, P. R., Boran, G. P., & Maher, V. M. G. (2006) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf03167964 · Cited by 90
Time trends in population cholesterol levels 1986–2004: influence of lipid‐lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study
Eliasson, M., Janlert, U., Jansson, J.-H., & Stegmayr, B. G. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01730.x · Cited by 88
Ventricular Arrhythmias and Risk of Death and Acute Myocardial Infarction in Apparently Healthy Subjects of Age ≥55 Years
Sajadieh, A., Nielsen, O. W., Rasmussen, V., Hein, H. O., Frederiksen, B. S., Davanlou, M., & Hansen, J. F. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.067 · Cited by 91
The influence of hospitalisation on drug prescription in primary care – a large-scale follow-up study
Grimmsmann, T., Schwabe, U., & Himmel, W. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0325-1 · Cited by 90
“Cardiovascular diseases are the main reason for admission into hospital, and statins are recommended for the affected patients [25].”
Background
ESC Study Group of Sports Cardiology: recommendations for participation in leisure-time physical activity and competitive sports for patients with ischaemic heart disease
Börjesson, M., Assanelli, D., Carré, F., Dugmore, D., Panhuyzen-Goedkoop, N. M., Seiler, C. A., Senden, J., & Solberg, E. E. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000199494.46708.5a · Cited by 87
Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care
Guglielmi, V., Bellia, A., Pecchioli, S., Della‐Morte, D., Parretti, D., Cricelli, I., Medea, G., Sbraccia, P., Lauro, D., Cricelli, C. A., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.018 · Cited by 91
Lipids and CVD management: towards a global consensus
Ballantyne, C. M., Arroll, B., & Shepherd, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi373 · Cited by 86
Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy
Walldius, G., & Jungner, I. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi077 · Cited by 88
Cardiac telerehabilitation as an alternative to centre-based cardiac rehabilitation
Brouwers, R. W. M., van Exel, H. J., van Hal, J. M. C., Jorstad, H. T., de Kluiver, E. P., Kraaijenhagen, R. A., Kuijpers, P. M. J. C., van der Linde, M. R., Spee, R. F., Sunamura, M., et al. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01432-y · Cited by 97
The Potential of Myocardial Perfusion Scintigraphy for Risk Stratification of Asymptomatic Patients With Type 2 Diabetes
Bax, J. J., Bonow, R. O., Tschöpe, D., Inzucchi, S. E., & Barrett, E. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.077 · Cited by 88
High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients
Bruckert, É., Baccara‐Dinet, M. T., McCoy, F., & Chapman, J. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x74871 · Cited by 88
Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic heart failure
Craenenbroeck, E. M. V., Beckers, P. J., Possemiers, N. M., Wuyts, K., Frederix, G., Hoymans, V. Y., Wuyts, F. L., Paelinck, B. P., Vrints, C. J. M., & Conraads, V. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq058 · Cited by 87
Primary Prevention of Cardiovascular Diseases in General Practice: Mismatch between Cardiovascular Risk and Patients' Risk Perceptions
van der Weijden, T., van Steenkiste, B., Stoffers, J., Timmermans, D. R. M., & Grol, R. P. T. M. (2007) · Medical Decision Making · doi:10.1177/0272989x07305323 · Cited by 87
Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health?
Meyer, B. J. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.010 · Cited by 87
The independent relationship between triglycerides and coronary heart disease
Morrison, A. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4311 · Cited by 87
Population‐attributable risk of coronary heart disease risk factors during long‐term follow‐up: the Malmö Preventive Project
Nilsson, P. M., Nilsson, J., & Berglund, G. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01671.x · Cited by 87
Smoking behaviour in European patients with established coronary heart disease
Reimer, W. J. M. S. O., de Swart, E. A. M., Bacquer, D. D., Pyörälä, K., Keil, U., Heidrich, J., Deckers, J. W., Kotseva, K., Wood, D., & Boersma, E. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi497 · Cited by 86
Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence
Maki, K. C., Bays, H. E., & Dicklin, M. R. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.003 · Cited by 83
Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort Study
Marcus, M. W., Müskens, R. P. H. M., Ramdas, W. D., Wolfs, R. C. W., de Jong, P. T. V. M., Vingerling, J. R., Albert Hofman, D., Stricker, B. H. C., & Jansonius, N. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029724 · Cited by 85
Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication
Golledge, J., Leicht, A. S., Crowther, R. G., Clancy, P., Spinks, W. L., & Quigley, F. G. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.09.006 · Cited by 85
Enhancing the efficacy of the 20 m multistage shuttle run test
Flouris, A. D., Metsios, G. S., & Koutedakis, Y. (2005) · British Journal of Sports Medicine · doi:10.1136/bjsm.2004.012500 · Cited by 87
Common Carotid Intima-Media Thickness Measurements Do Not Improve Cardiovascular Risk Prediction in Individuals With Elevated Blood Pressure
Bots, M. L., Groenewegen, K. A., Anderson, T. J., Britton, A. R., Dekker, J. M., Engström, G., Evans, G., Graaf, J. D., Grobbee, D. E., Hedblad, B., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02683 · Cited by 84
DNA methylation biomarkers of myocardial infarction and cardiovascular disease
Fernández‐Sanlés, A., Sayols-Baixeras, S., Subirana, I., Sentı́, M., Pérez-Fernández, S., Moura, M. D. C., Esteller, M., Marrugat, J., & Elosúa, R. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01078-6 · Cited by 84
Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program
Shepherd, J., Vidt, D. G., Miller, E., Harris, S., & Blasetto, J. W. (2007) · Cardiology · doi:10.1159/000100908 · Cited by 84
Secondary prevention programmes for coronary heart disease: a meta-regression showing the merits of shorter, generalist, primary care-based interventions
Clark, A. M., Hartling, L., Vandermeer, B., Lissel, S. L., & McAlister, F. A. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328013f11a · Cited by 85
Poor oral hygiene and gingivitis are associated with obesity and overweight status in paediatric subjects
Franchini, R., Petri, A., Migliario, M., & Rimondini, L. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2011.01770.x · Cited by 85

Authors: De Backer, G.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2003-09
Volume: 24
Issue: 17
Pages: 1601-1610
ISSN: 0195-668X (ISSN-L)
DOI: 10.1016/s0195-668x(03)00347-6
OpenAlex: W2153788691
Cited by: 2,251
References: 0
Citations by year: 2026: 4 · 2025: 7 · 2024: 15 · 2023: 19 · 2022: 12 · 2021: 55 · 2020: 64 · 2019: 92 · 2018: 65 · 2017: 67 · 2016: 51 · 2015: 57 · 2014: 78 · 2013: 87 · 2012: 98
FWCI: 206.41
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: cardiovascular disease prevention, guideline development methodology, quality of evidence, clinical decision-making, guideline implementation, cardiovascular risk management
MeSH terms: Smoking Prevention, Blood Pressure, Cardiovascular Diseases, Diagnostic Imaging, Diet, Europe, Health Priorities, Humans, Lipids, Risk Factors, Exercise, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks